Ayurvedic management of Type 2 diabetic through virechana karma

A clinico comparative study off Virechana Karma as Shodhans followed by mustadi kwath as shamana and only mustadi kwath as shaman Chikitsa in the management of Santarpanottha Prmeha W. S. R. to type 2 Diabetes mellitus - An open labeled randomised trail - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083578

Enrollment

Registered

2025-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Classical signs and symptoms of Santarpanottha Prameha (Diabetes mellitus type2) described in Ayurvedic classics as well as modern science 2 Patient having classical signs and symptoms of the disease as per Ayurveda as well as modern science 3 Patients of NIDDM with blood FBS equal to or more than 126 mg/dl or PPBS equal to or more than 200mg/dl 4 Age group of 18 to 60 years 5 Diabetes chronicity more than 10 years 6 Hb1Ac greater than 6 7 Patient otherwise healthy and fit for Virechana therapy

Exclusion criteria

Exclusion criteria: 1 Patients of Type-1 Diabetes or the patients of Type-2 Diabetes taking Insulin 2 Patients having history of any major complications of Diabetes like Nephropathy Retinopathy Diabetic Foot Carbuncles etc 3 Age less than18 and more than 60 years 4 Patient of Type-2 Diabetes mellitus having blood sugar level more than 400 mg/dl 5 Patients having history of any cardiovascular disease renal disease or any other disease affecting multiple body systems and pregnancy etc

Design outcomes

Primary

Measure	Time frame
Outcomes will be assessed on the basis of subjective and objective: Subjective Criteria Chief complain 1 Avila Mutrata (turbidity) 2 Prabhuta Mutrata 3 Mutra Madhuryata (glycosuria) 3 Pipasa Adhikya (polydypsia) 4 Kshudha Adhikya (polyphagia) 5 Swedadhikya (perspiration) 6 Angagandha (bad dour from the body parts) 7 Nidra Adhikya 8 Kara Pada Suptata 9 kara Pada Tala Daha Objective Criteria RBS FBS PPBS HbA1c Timepoint: Daily assessment of treatment plan	—

Measure

Time frame

Outcomes will be assessed on the basis of subjective and objective: Subjective Criteria Chief complain 1 Avila Mutrata (turbidity) 2 Prabhuta Mutrata 3 Mutra Madhuryata (glycosuria) 3 Pipasa Adhikya (polydypsia) 4 Kshudha Adhikya (polyphagia) 5 Swedadhikya (perspiration) 6 Angagandha (bad dour from the body parts) 7 Nidra Adhikya 8 Kara Pada Suptata 9 kara Pada Tala Daha Objective Criteria RBS FBS PPBS HbA1c Timepoint: Daily assessment of treatment plan

—

Secondary

Measure	Time frame
Timepoint: ;Patient will be assessed by blood investigation: RBS FBS PPBS HbA1cTimepoint: Assessment and follow up after treatment every week up to two week	—

Countries

India

Contacts

Public ContactVdMahima Patel

Government Akhandanand Ayurveda College

rohinirakesh2@gmail.com9313001450

Outcome results